Prion diseases are fatal neurodegenerative disorders that affect humans and animals and for which no pharmacological treatment is available. Compounds consisting of two identical moieties joined via an appropriate spacer (i.e. bivalent compounds) have turned out to be effective tools to prevent prion fibril formation and exhibit an improved biological profile with regard to the corresponding monovalent derivatives. In this review we discuss the importance of the bivalent strategy as a viable approach to design new chemical entities to combat prion diseases.
Modulation of Prion by Small Molecules: From Monovalent to Bivalent and Multivalent Ligands / Staderini, M; Legname, Giuseppe; Bolognesi, Ml; Menéndez, Jc. - In: CURRENT TOPICS IN MEDICINAL CHEMISTRY. - ISSN 1873-4294. - 13:19(2013), pp. 2491-2503. [10.2174/15680266113136660176]
Modulation of Prion by Small Molecules: From Monovalent to Bivalent and Multivalent Ligands
Legname, Giuseppe;
2013-01-01
Abstract
Prion diseases are fatal neurodegenerative disorders that affect humans and animals and for which no pharmacological treatment is available. Compounds consisting of two identical moieties joined via an appropriate spacer (i.e. bivalent compounds) have turned out to be effective tools to prevent prion fibril formation and exhibit an improved biological profile with regard to the corresponding monovalent derivatives. In this review we discuss the importance of the bivalent strategy as a viable approach to design new chemical entities to combat prion diseases.| File | Dimensione | Formato | |
|---|---|---|---|
|
0010R.pdf
non disponibili
Tipologia:
Versione Editoriale (PDF)
Licenza:
Non specificato
Dimensione
387.98 kB
Formato
Adobe PDF
|
387.98 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
